EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
14th May 2026 15:11
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.215p on 26-06-2026 at 17:05:15 |
|---|---|
| Change | -0.02p -8.51% |
| Buy | 0.22p |
| Sell | 0.21p |
| Last Trade: | Buy 14,004.00 at 0.22p |
| Day's Volume: | 8,009,445 |
| Last Close: | 0.215p |
| Open: | 0.235p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.215p - 0.235p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £4.62m |
| VWAP: | 0.218316p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 14,004 | 0.22p | Ordinary |
15:53:29 - 26-Jun-26 |
| Buy* | 14,004 | 0.22p | SI Trade |
15:53:29 - 26-Jun-26 |
| Sell* | 2,764,681 | 0.2135p | Ordinary |
15:53:12 - 26-Jun-26 |
| Buy* | 10,000 | 0.217p | Ordinary |
15:00:10 - 26-Jun-26 |
| Buy* | 14,004 | 0.22p | Ordinary |
14:14:57 - 26-Jun-26 |
| Buy* | 14,379 | 0.22p | SI Trade |
14:14:57 - 26-Jun-26 |
| Buy* | 5,000 | 0.22p | SI Trade |
14:14:57 - 26-Jun-26 |
| Sell* | 1,000,000 | 0.2131p | Ordinary |
14:14:34 - 26-Jun-26 |
| Sell* | 1,000,000 | 0.22p | Ordinary |
13:57:02 - 26-Jun-26 |
| Unknown* | 2,945,169 | 0.2231p | Ordinary |
13:01:53 - 26-Jun-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |